Urea, N-(3,4-dichlorophenyl)-N'-[3-[(4-quinazolinylamino)methyl]phenyl]-

Urea, N-(3,4-dichlorophenyl)-N'-[3-[(4-quinazolinylamino)methyl]phenyl]- Suppliers list
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Jinan Jiuli Biotechnology Co. , Ltd.  
Tel: 15865264761
Email: 486064515@qq.com
Company Name: ChemeGen  
Tel: 18818260767
Email: 2625930290@qq.com
Company Name: Beijing Biocreative Technology Co., Ltd.  
Tel: 15522676233
Email: 3007606172@qq.com

Urea, N-(3,4-dichlorophenyl)-N'-[3-[(4-quinazolinylamino)methyl]phenyl]- manufacturers

  • CAY10773
  • CAY10773 pictures
  • $1690.00
  • 2026-05-11
  • CAS:1648546-79-5
  • Purity:
  • Supply Ability: 10g
Urea, N-(3,4-dichlorophenyl)-N'-[3-[(4-quinazolinylamino)methyl]phenyl]- Basic information
Product Name:Urea, N-(3,4-dichlorophenyl)-N'-[3-[(4-quinazolinylamino)methyl]phenyl]-
Synonyms:Urea, N-(3,4-dichlorophenyl)-N'-[3-[(4-quinazolinylamino)methyl]phenyl]-;CAY10773;CAY-10773,CAY10773;N-(3,4-dichlorophenyl)-N′-[3-[(4-quinazolinylamino)methyl]phenyl]-urea;Anticancer agent 251
CAS:1648546-79-5
MF:C22H17Cl2N5O
MW:438.31
EINECS:
Product Categories:
Mol File:1648546-79-5.mol
Urea, N-(3,4-dichlorophenyl)-N'-[3-[(4-quinazolinylamino)methyl]phenyl]- Structure
Urea, N-(3,4-dichlorophenyl)-N'-[3-[(4-quinazolinylamino)methyl]phenyl]- Chemical Properties
Boiling point 547.5±50.0 °C(Predicted)
density 1.488±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF: 1 mg/ml,DMSO: 1 mg/ml
form A crystalline solid
pka12.87±0.70(Predicted)
Safety Information
MSDS Information
Urea, N-(3,4-dichlorophenyl)-N'-[3-[(4-quinazolinylamino)methyl]phenyl]- Usage And Synthesis
UsesAnticancer agent 251 (compound 7j) can induce cell death of bladder cancer cell T24 by inducing apoptosis, autophagy or ferroptosis[1].
Biological ActivityCAY10773 is a derivative of the ferroptosis inducer sorafenib .1 It selectively inhibits proliferation of BEL-7402, MGC803, and T24 bladder cancer cells (IC50s = 5.77, 5.21 and 3.97 μM, respectively) over non-cancerous HCV-29 cells (IC50 = 23.19 μM). CAY10773 induces apoptosis in T24 cells when used at concentrations ranging from 2 to 6 μM but induces ferroptosis at concentrations greater than or equal to 6 μM with 10 hour or longer incubation times. It increases the production of reactive oxygen species (ROS) and decreases the mitochondrial membrane potential in T24 cells. CAY10773 (≥6 μM) also induces autophagy with incubation times longer than eight hours.
References1.Chen, J.-N., Li, T., Cheng, L., et al.Synthesis and in vitro anti-bladder cancer activity evaluation of quinazolinyl-arylurea derivativesEur. J. Med. Chem.205112661(2020)
Urea, N-(3,4-dichlorophenyl)-N'-[3-[(4-quinazolinylamino)methyl]phenyl]- Preparation Products And Raw materials
Tag:Urea, N-(3,4-dichlorophenyl)-N'-[3-[(4-quinazolinylamino)methyl]phenyl]-(1648546-79-5) Related Product Information
CEPHALOTAXINE Copper, tribromobis[μ-[methyl N-[di(2-pyridinyl-κN)methylene]carbonodithiohydrazonato-κN,κS']]tri- Elesclomol 2-Furancarboxamide, 5-nitro-N-[4-[7-(1,2,3,6-tetrahydro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]phenyl]- Brevilin A Doxorubicin hydrochloride